Cargando…
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834422/ https://www.ncbi.nlm.nih.gov/pubmed/31645480 http://dx.doi.org/10.18632/aging.102385 |
| _version_ | 1783466485450014720 |
|---|---|
| author | Chatterjee, Shilpak Chakraborty, Paramita Mehrotra, Shikhar |
| author_facet | Chatterjee, Shilpak Chakraborty, Paramita Mehrotra, Shikhar |
| author_sort | Chatterjee, Shilpak |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6834422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Impact Journals |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68344222019-11-13 CD38-NAD(+)-Sirt1 axis in T cell immunotherapy Chatterjee, Shilpak Chakraborty, Paramita Mehrotra, Shikhar Aging (Albany NY) Editorial Impact Journals 2019-10-23 /pmc/articles/PMC6834422/ /pubmed/31645480 http://dx.doi.org/10.18632/aging.102385 Text en Copyright © 2019 Chatterjee et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Chatterjee, Shilpak Chakraborty, Paramita Mehrotra, Shikhar CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title | CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title_full | CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title_fullStr | CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title_full_unstemmed | CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title_short | CD38-NAD(+)-Sirt1 axis in T cell immunotherapy |
| title_sort | cd38-nad(+)-sirt1 axis in t cell immunotherapy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834422/ https://www.ncbi.nlm.nih.gov/pubmed/31645480 http://dx.doi.org/10.18632/aging.102385 |
| work_keys_str_mv | AT chatterjeeshilpak cd38nadsirt1axisintcellimmunotherapy AT chakrabortyparamita cd38nadsirt1axisintcellimmunotherapy AT mehrotrashikhar cd38nadsirt1axisintcellimmunotherapy |